Ozen A, Lenardo MJ. Protein-losing enteropathy. N Engl J Med. 2023;389:733–48.

Article  CAS  PubMed  Google Scholar 

Rezvani AR, Storer BE, Storb RF, Mielcarek M, Maloney DG, Sandmaier BM, et al. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011;17:1594–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venegas-Gómez VA, Ruiz-Manríquez J, Falcón-Antonio OE, Zamora-Nava LE. Protein-losing enteropathy secondary to graft-versus-host disease. Rev Esp Enferm Dig. 2024;116:238–9.

PubMed  Google Scholar 

Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22:4–10.

Article  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. WHO classification of tumours series. 5th ed. Vol. 11. Lyon: International Agency for Research on Cancer; 2024. p. 394–398.

Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, et al. Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation. Int J Hematol. 2019;109:197–205.

Article  CAS  PubMed  Google Scholar 

Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;1994(15):825–8.

Google Scholar 

Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, et al. T cell recruitment to the intestinal stem cell compartment drives immune-mediated intestinal damage after allogeneic transplantation. Immunity. 2019;51:90-103.e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murthy HS, Sheets K, Kumar A, Nishihori T, Mina A, Chavez JC, et al. Hypoalbuminemia at day +90 is associated with inferior non-relapse mortality and overall survival in allogeneic hematopoietic cell transplantation recipients: a confirmatory study. Biol Blood Marrow Transplant. 2018;24:400–5.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Otero P, Porcher R, Peffault de Latour R, Contreras M, Bouhnik Y, Xhaard A, et al. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. Blood. 2012;119:5909–17.

Article  CAS  PubMed  Google Scholar 

Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, et al. α1-antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 2018;131:1372–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott AP, Tey SK, Butler J, Kennedy GA. Diagnostic utility of endoscopy and biopsy in suspected acute gastrointestinal graft-versus-host disease after hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2018;24:1294–8.

Article  PubMed  Google Scholar 

Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology. 2001;219:86–90.

Article  CAS  PubMed  Google Scholar 

Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382:1800–10.

Article  PubMed  Google Scholar 

Muroi K, Miyamura K, Ohashi K, Murata M, Eto T, Kobayashi N, et al. Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. Int J Hematol. 2013;98:206–13.

Article  CAS  PubMed  Google Scholar